Cargando…
Synergic effect of Eicosapentaenoic acid and Lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cells
BACKGROUND: PUFAs are potent inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, an enzyme catalyzing the conversion of HMGCoA to mevalonate, the rate limiting step in cholesterol biosynthesis. Statins represent a class of drugs that are widely used to treat hypercholesterolemia...
Autores principales: | Notarnicola, Maria, Messa, Caterina, Refolo, Maria G, Tutino, Valeria, Miccolis, Angelica, Caruso, Maria G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001710/ https://www.ncbi.nlm.nih.gov/pubmed/21118482 http://dx.doi.org/10.1186/1476-511X-9-135 |
Ejemplares similares
-
Polyunsaturated fatty acids reduce Fatty Acid Synthase and Hydroxy-Methyl-Glutaryl CoA-Reductase gene expression and promote apoptosis in HepG2 cell line
por: Notarnicola, Maria, et al.
Publicado: (2011) -
Inhibition of HMGCoA reductase by simvastatin protects mice from injurious mechanical ventilation
por: Manitsopoulos, Nikolaos, et al.
Publicado: (2015) -
Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients
por: Grover, Abhinav, et al.
Publicado: (2017) -
Functional food mixtures: Inhibition of lipid peroxidation, HMGCoA reductase, and ACAT2 in hypercholesterolemia‐induced rats
por: Mohd Rosmi, Noor Syafiqa Aqila, et al.
Publicado: (2020) -
Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase
por: Kato, S, et al.
Publicado: (2010)